Impact of rosuvastatin versus atorvastatin on coronary atherosclerotic plaque volume – a systematic review and meta-analysis with trial sequential analysis of randomized control trials
Restricted accessResearch articleFirst published online December, 2020
Impact of rosuvastatin versus atorvastatin on coronary atherosclerotic plaque volume – a systematic review and meta-analysis with trial sequential analysis of randomized control trials
SacksFMPfefferMAMoyeLA, et al.The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med1996; 335: 1001–1009.
2.
YusufSBoschJDagenaisG, et al.Cholesterol lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med2016; 374: 2021–2031.
3.
WengTCYangYHLinSJ, et al.A systematic review and meta – analysis on the therapeutic equivalence of statins. J Clin Pharm Ther2010; 35: 139–151.
4.
NichollsSJBallantyneCMBarterPJ, et al.Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med2011; 365: 2078–2087.
5.
DohiTMiyauchiKOkazakiS, et al.Plaque regression determined by intravascular ultrasound predicts long-term outcomes of patients with acute coronary syndrome. J Atheroscler Thromb2011; 18: 231–239.
6.
SchieleFEcarnotFChopardR. Coronary artery disease: Risk stratification and patient selection for more aggressive secondary prevention. Eur J Prev Cardiol2017; 24: 88–100.
7.
ThondapuVKuriharaOYonetsuT, et al.Comparison of rosuvastatin versus atorvastatin for coronary plaque stabilization. Am J Cardiol2019; 123: 1565–1571.
8.
BrinjikjiWLehmanVTKallmesDF, et al.The effects of statin therapy on carotid plaque composition and volume: A systematic review and meta-analysis. J Neuroradiol2017; 44: 234–240.
9.
FurmanCCopinCKandoussiM, et al.Rosuvastatin reduces MMP-7 secretion by human monocyte-derived macrophages: Potential relevance to atherosclerotic plaque stability. Atherosclerosis2004; 174: 93–98.
10.
PanesOGonzálezCHidalgoP, et al.Platelet tissue factor activity and membrane cholesterol are increased in hypercholesterolemia and normalized by rosuvastatin, but not by atorvastatin. Atherosclerosis2017; 257: 164–171.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
